GeneDx Holdings Valuation
| WGS Stock | 79.43 1.09 1.35% |
At this time, the firm appears to be overvalued. GeneDx Holdings Corp retains a regular Real Value of USD43.86 per share. The prevalent price of the firm is USD79.43. Our model calculates the value of GeneDx Holdings Corp from evaluating the firm fundamentals such as Return On Equity of -0.36, return on asset of -0.0827, and Current Valuation of 2.18 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GeneDx Holdings' valuation include:
Price Book 10.6701 | Enterprise Value 2.2 B | Enterprise Value Ebitda (0.83) | Price Sales 8.1655 | Enterprise Value Revenue 8.1642 |
Overvalued
Today
Please note that GeneDx Holdings' price fluctuation is not too volatile at this time. Calculation of the real value of GeneDx Holdings Corp is based on 3 months time horizon. Increasing GeneDx Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GeneDx stock is determined by what a typical buyer is willing to pay for full or partial control of GeneDx Holdings Corp. Since GeneDx Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeneDx Stock. However, GeneDx Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.43 | Real 43.86 | Target 9.88 | Hype 70.43 | Naive 81.48 |
The intrinsic value of GeneDx Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeneDx Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeneDx Holdings Corp helps investors to forecast how GeneDx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeneDx Holdings more accurately as focusing exclusively on GeneDx Holdings' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GeneDx Holdings' intrinsic value based on its ongoing forecasts of GeneDx Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GeneDx Holdings' closest peers.
GeneDx Holdings Cash |
|
GeneDx Valuation Trend
GeneDx Holdings' real value is important for investors to make better decisions and a more accurate overall view of GeneDx Holdings' financial worth over time. Using both GeneDx Holdings' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
GeneDx Revenue by Product
GeneDx Holdings Total Value Analysis
GeneDx Holdings Corp is at this time forecasted to have company total value of 2.18 B with market capitalization of 2.18 B, debt of 119.77 M, and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the GeneDx Holdings fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.18 B | 2.18 B | 119.77 M |
GeneDx Holdings Investor Information
About 18.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 3.09. GeneDx Holdings Corp had not issued any dividends in recent years. The entity had 1:33 split on the 4th of May 2023. Based on the key indicators related to GeneDx Holdings' liquidity, profitability, solvency, and operating efficiency, GeneDx Holdings Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.GeneDx Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. GeneDx Holdings has an asset utilization ratio of 42.76 percent. This implies that the Company is making USD0.43 for each dollar of assets. An increasing asset utilization means that GeneDx Holdings Corp is more efficient with each dollar of assets it utilizes for everyday operations.GeneDx Holdings Ownership Allocation
GeneDx Holdings Corp has a total of 27.47 Million outstanding shares. The majority of GeneDx Holdings Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in GeneDx Holdings to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in GeneDx Holdings Corp. Please pay attention to any change in the institutional holdings of GeneDx Holdings Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.GeneDx Holdings Profitability Analysis
The company reported the last year's revenue of 202.57 M. Reported Net Loss for the year was (175.77 M) with loss before taxes, overhead, and interest of (26.75 M).About GeneDx Holdings Valuation
The stock valuation mechanism determines GeneDx Holdings' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of GeneDx Holdings Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of GeneDx Holdings. We calculate exposure to GeneDx Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GeneDx Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 60.6 M | 63.7 M | |
| Pretax Profit Margin | (0.87) | (0.92) | |
| Operating Profit Margin | (0.81) | (0.85) | |
| Net Loss | (0.87) | (0.91) | |
| Gross Profit Margin | 0.30 | 0.31 |
GeneDx Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as GeneDx Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.3 M |
GeneDx Holdings Current Valuation Indicators
GeneDx Holdings' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GeneDx Holdings' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GeneDx Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GeneDx Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GeneDx Holdings' worth.Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.